Altimmune Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
ALT$2.12+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
15. Subsequent Events
The Company evaluated subsequent events through the issuance date of the financial statements. During January and February 2025, the Company raised $30.2 million in net proceeds through the issuance of 4,467,866 shares of common stock under the 2023 Shelf.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.